Quantcast

Latest Baxter International Stories

2009-06-13 11:01:00

Illinois-based Baxter International Inc. said it expects by early July to release the first commercially available dosages of H1N1 swine flu vaccine. Baxter, based in Deerfield, Ill., is one of several vaccine makers working with the World Health Organization and the U.S. Centers for Disease Control to combat the virus, which WHO this week declared a global pandemic. Baxter's cell-based technology yields vaccines in about 13 weeks, as compared to the 24 weeks needed for an older process where...

2009-05-22 08:59:00

CHICAGO, May 22 /PRNewswire/ -- "Options News," hosted by Carrie Long and www.ONN.tv Chief Investment Strategist Jud Pyle, reviews the latest developments in the options and stock markets. (Logo: http://www.newscom.com/cgi-bin/prnh/20090323/AQM046LOGO) Today's program continues to look at healthcare stocks, as Baxter International (BAX) saw some unusual options activity in the November series. Elsewhere on the options front, the Bank of America (BAC) November options were active as well...

2009-05-12 15:34:29

U.S. health officials are investigating whether the blood thinner heparin is linked to two patient deaths, the product's maker says. Baxter International Inc. of Deerfield, Ill., said Tuesday the U.S. Food and Drug Administration and a Delaware hospital were looking into whether medical providers were using heparin contained in intravenous bags when the patients died, The Chicago Tribune reported. The use of heparin has been suspended at Beebe Medical Center in Lewes, Del., Friday, where five...

2009-04-27 16:11:00

DEERFIELD, Ill., April 27 /PRNewswire-FirstCall/ -- Baxter International (NYSE: BAX), will host its annual shareholders meeting on Tuesday, May 5, 2009, at 11:30 a.m. Eastern Time (10:30 a.m. Central Time) This call is being webcast by Thomson/CCBN and can be accessed at Baxter's Web site at http://www.baxter.com/. The conference call will be recorded by Baxter and is copyrighted material. It cannot be recorded or rebroadcast without Baxter's permission. The webcast is also being...

2009-04-15 13:46:00

World Hemophilia Day brings together the global bleeding disorders community MONTREAL, April 15 /PRNewswire/ -- Behind every person with hemophilia is a much needed team of support. This April 17 marks the 20th anniversary of World Hemophilia Day where hemophilia organizations around the world increase awareness of hemophilia and other bleeding disorders. This year's World Hemophilia Day campaign, "Together, We Care", focuses on the importance of comprehensive care, which is central to...

2009-04-13 15:00:00

DEERFIELD, Ill., April 13 /PRNewswire-FirstCall/ -- Baxter International (NYSE: BAX), will host a quarterly conference call to discuss its first quarter 2009 financial results on Thursday, April 16, 2009, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). To access the call, please dial 866-238-0637 (domestic) or 703-639-1156 (international). Please dial into the call at least ten minutes prior to the start of the call for the operator to connect you. This call is being webcast by...

2009-01-19 15:07:00

DEERFIELD, Ill., Jan. 19 /PRNewswire-FirstCall/ -- Baxter International (NYSE: BAX), will host a quarterly conference call to discuss its fourth quarter 2008 financial results on Thursday, January 22, 2009, at 8:30 a.m. Eastern Time (7:30 a.m. Central Time). To access the call, please dial 866- 238-0637 (domestic) or 703-639-1156 (international). Please dial into the call at least ten minutes prior to the start of the call for the operator to connect you. This call is being webcast...

2009-01-05 07:00:00

DEERFIELD, Ill. and SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Baxter International Inc. and Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced the start of a Phase III clinical trial of Baxter's GAMMAGARD LIQUID [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze(TM) Technology) for the treatment of primary immunodeficiency (PID). The purpose of this clinical trial is to...

2008-12-22 11:36:24

The cause of an outbreak of severe adverse reactions that occurred at hemodialysis facilities across the country early this year has been identified. Vials of heparin manufactured by Baxter Healthcare and contaminated with oversulfated chondroitin sulfate (OSCS) have been shown to be responsible for a widespread outbreak of adverse reactions to hemodialysis treatment that affected 152 people and covered 13 states. Reactions to the contaminated heparin included facial edema, or swelling, low...

2008-11-04 18:00:19

Baxter International Inc. (NYSE: BAX) announced today that it will present at the 2008 Annual Credit Suisse Health Care Conference on Wednesday, November 12, 2008 at 8:30 a.m. (MST) or 10:30 a.m. (EST). The live webcast of Baxter's presentation can be accessed from the Baxter corporate website at http://investor.baxter.com/phoenix.zhtml?c=86121&p=irol-EventDetails&E ventId=2012057 and will be available for replay through December 11, 2008. Baxter International Inc. develops,...


Word of the Day
siliqua
  • A Roman unit of weight, 1⁄1728 of a pound.
  • A weight of four grains used in weighing gold and precious stones; a carat.
  • In anatomy, a formation suggesting a husk or pod.
  • The lowest unit in the Roman coinage, the twenty-fourth part of a solidus.
  • A coin of base silver of the Gothic and Lombard kings of Italy.
'Siliqua' comes from a Latin word meaning 'a pod.'
Related